From midlife on, muscle strength declines, approximately one percent annually [4].
Moreover, it has been demonstrated that trunk muscle strength declines at a higher percentage in older adults [ 3, 20].
Muscle strength declines at a rate of 3-43-4%r year in men and 2.5 3% per year in women aged 75 years [ 9].
The overall muscle strength declined, as an inability to climb stairs without railing, to arise from a chair, to get up from a prone position or to arise from bed became the characteristic features.
Between 1 and 12 months of age, total and limb lean mass gains were lower in PPARβ−/− vs PPARβ+/+, and muscle strength declined in PPARβ−/−, whereas it remained stable for PPARβ+/+.
In this study, we observed that both muscle mass and muscle strength declined with advancing age in older adults, and that women have a relatively lower muscle mass and strength compared with men of the same age, and these findings are consistent with previous research [ 8- 10, 28- 30].
It is known that muscle strength declines by 15% per decade after the age of 50 years and by 30% per decade after the age of 70, leading to sarcopenia. 4 The prevalence of sarcopenia varies from 6% to 24%, depending on the geographical location, diagnostic tool, and cutoff points used.
Muscle strength declines 4% per day during the first week of immobilisation, and the deficits in the involved hip after THR range from 10-21% when compared to the uninvolved hip at 1 year post-surgery, [ 12, 13] the atrophic changes that occur about the hip persist up to 2 years following THR, [ 10].
Muscle strength declines on average by one percent annually from midlife on.
We propose that an active lifestyle is an important determinant of quality of life and molecular progression of aging in skeletal muscle of the elderly, and is a viable therapy for attenuating and/or reversing skeletal muscle strength declines and mitochondrial abnormalities associated with aging.
